HBV DNA with undetectable HBV surface antigen (HBsAg) outside the pre-23 seroconversion window period. The mechanisms leading to OBI remain largely 24 unknown. The potential role of specific amino acid substitutions in the S protein 25 from OBI on HBsAg production and excretion was examined in vitro. HBsAg was 26 quantified in culture supernatants and cell extracts of HuH-7 cells transiently 27 transfected with plasmids containing the S gene of eight HBsAg+ controls and 18 28 OBI clones. The intracellular (IC)/extracellular (EC) HBsAg production ratio was 29 ~1.0 for the majority of controls. Three IC/EC HBsAg patterns were observed in 30 OBI strains clones: pattern 1 defined as IC/EC ratio 1.0 in 5/18 OBI clones; 31 pattern 2 with detectable IC but low or undetectable EC HBsAg (IC/EC: 7.0-800) 32 in 6/18 OBIs; and pattern 3 with both low or undetectable IC and EC HBsAg in 33 7/18 clones. Intracellular immunofluorescence staining showed that, in pattern 2, 34
HBsAg was concentrated around the nucleus suggesting retention in the 35 endoplasmic reticulum. Substitutions M75T, Y100S or P178R were present in 36 4/6 pattern 2 OBI clones. Site-directed mutagenesis-corrected mutations 37 reversed HBsAg excretion to pattern 1 and, when introduced in a control clone, 38 induced pattern 2 except for Y100S. In a control and several OBIs, variants of a 39
given quasispecies expressed HBsAg according to different patterns. However, 40
INTRODUCTION 44
Occult HBV infection/carriage (OBI) is characterized by the presence of very low 45 levels of HBV DNA in plasma and/or in liver with undetectable hepatitis B surface 46 antigen (HBsAg) using the most sensitive commercial assays, with or without 47 antibodies to hepatitis core antigen (anti-HBc) or hepatitis B surface antigen 48 (anti-HBs), outside the pre-seroconversion window period (1) . OBI represents a 49 particular form of persistent or chronic infection that is encountered globally 50 albeit at different frequencies depending on endemicity level and genotype (2) . 51
OBI is a potential source of HBV transmission by transfusion and organ 52 transplantation, can reactivate in association with immunodeficiency or 53 immunosuppressive treatments, and might be a risk factor for liver cancer (2). 54
Several mechanisms have been proposed as responsible for OBI such as 55 imperfect control by the host immune system (3, 4), multiple amino acid 56 substitutions in the S protein affecting HBsAg detection with commercial 57
immunoassays (5, 6), mutations in regulatory elements negatively affecting virus 58 replication (7, 8) , and mutations affecting post-transcriptional mechanisms 59 regulating S protein expression (9, 10) . 60
MATERIAL AND METHODS 72
Cloning and sequencing of HBV S protein coding region, HBsAg 73 expression plasmid, and site-directed mutagenesis. HBV DNA was isolated 74 from randomly selected plasma of 18 previously characterized blood donors with 75 OBI and eight HBsAg+ blood donors as controls (10). Fifteen, two, and one OBI 76 donors were infected with HBV genotype B, C, and D, respectively. Two HBsAg+ 77 control samples contained genotype B, four genotype C, and two genotype D 78 strains. A detailed description of OBI and HBsAg+ control donors is provided in 79 Table 1 . 80
The whole HBV genome was initially PCR-amplified and a consensus viral 81 sequence was obtained by direct sequencing of the PCR products as previously 82 In HBsAg+ controls, the average normalized total HBsAg production was 166 >120 ng/3x10 5 cells (range: 123-613 ng) at 72h post-transfection (Fig. 2) . Six 167 control clones showed an IC/EC HBsAg ratio ranging between 0.2 and 3.0. 168
HBsAg intra-cellular immunofluorescence staining was diffuse and finely granular 169 across the hepatocyte cytoplasm (Fig. 3) . Two genotype C control clones (M92-170 cl2 and M95-cl8) showed IC/EC ratios >10.0 ( Fig. 2A) , and IC HBsAg 171 concentrated in the perinuclear area as densely packed fluorescence (data not 172 shown). 173
Three distinct patterns of HBsAg production were identified in cells 174 transfected with OBI clones ( Fig. 2A-D Fig. 2A ). Figure 2D consensual residues using SDM ( Table 2 ). Eight of the selected substitutions 210 were unique to the pattern 2 sequences studied (M75T, P105R, K160N, W165R, 211 L176P, W182C, V184A and I226N) whereas one (S167L) and six (Y100S, 212 P111S, G112E, G119E, S154P, and P178R) were also present in OBI pattern 1 213 and pattern 3 sequences, respectively. In addition, Q129R and A159V were 214 found in sequences associated with all three patterns. 215
HBsAg production pattern was not modified when 14 selected amino 216 acids were restored to the wild type residues by SDM individually or in 217 combinations (Table 2 ). In contrast, restoration of methionine 75 in sample 218 HK01556-cl2, tyrosine 100 in sample HK6794-cl2, and proline 178 in samples 219 HK3110-cl4 and HK3475-cl6 resulted in a significant increase of HBsAg 220 production (P=0.02-0.05, except HK01556-cl2) that was associated with 221 increased HBsAg excretion in culture supernatants as reflected in the decrease 222 of HBsAg IC/EC ratio observed (7-801 versus 0.125-4 after SDM). This finding 223 was confirmed in all four samples by immunofluorescence analysis showing a 224 change following SDM from the dense intra-cellular accumulation of HBsAg 225 associated with pattern 2 to a diffuse fluorescence across the cytoplasm typical 226 of pattern 1 (Fig. 4A ). These data were reproduced in the hepatocyte cell lineproduction that characterizes pattern 3 OBIs (Table 2 ). The P178R substitution 231 was not found in the sequences of 369 strains (124 genotype B, 95 genotype C 232 and 150 genotype D) from HBsAg+ donors, whereas M75T and Y100S were 233 present in one HBsAg+ sequence each. 234
To confirm the effect of substitutions M75T, Y100S, and P178R on HBsAg 235 excretion, these three substitutions were introduced into the genotype B HBsAg+ 236 control M88-cl4. OBI pattern 2 was reproduced in M88-cl4 following M75T and 237
P178R changes but not Y100S change, as evidenced by IC/EC ratio evaluation 238
and intra-cellular immunofluorescence analysis (Table 3 & Fig. 4B ). In addition, 239 the introduction of the mutation P178R by SDM in an entire HBV genotype C 240 genome changed the HBsAg production pattern 1 initially observed in HuH-7 241 transfected cells to pattern 2 (data not shown). In contrast, substitutions 242 P111S+G112E, G119E, Q129R, I150T, S154P, and W165R introduced in control 243 M88-cl4 did not substantially affect HBsAg production pattern (Table 3) . 244
The effect of amino acid changes at position 178 on M88-cl4 HBsAg 245 phenotype was investigated further (Table 3) . Substitutions P178A, P178E, 246 P178K, P178L, and P178Q resulted in a substantially decreased overall average 247 production of HBsAg (31-80 ng) compared to M88-cl4 wt (270 ng) as observed 248 with P178R (78 ng). However, the corresponding IC/EC HBsAg ratios were 249 slightly higher (IC/EC=2-5) than observed for M88-cl4 wt (IC/EC=0.33) but still 250 compatible with pattern 1 definition, and lower than the pattern 2-related IC/EC 251 ratio of P178R mutant (IC/EC=15). The IF results obtained with P178A/L/Q did 252 not match clearly with either pattern 1 or pattern 2 profiles and were considered 253 indeterminate (Fig. 5) . Mutant P178E showed a pattern 1-related IC/EC HBsAg 254 ratio and IFA profile similar to M88-cl4 wt. As shown in Figure 1 for the OBI phenotype was therefore examined by sequencing multiple clones 273 from several donor samples containing pattern 2 clones (Fig. 6) . 274
The diversity of pattern was shown in one control (M92 two clones pattern 275 mutations responsible for pattern 2 of clone 2 was present in a sub-cluster of five 281 clones associated with clone 2 but Y100F was present in all 12 other clones. In 282 contrast, in OBIs HK01556, HK3110 and HK3475, genetic diversity was very 283 limited (Fig. 6) , and each of the 8-12 clones contained Y100S (HK01556) or 284 P178R (HK3110 and HK3475). For these three OBI strains, it is likely that these 285 two mutations shown to prevent HBsAg excretion contribute to the OBI 286 The functional analysis of clones derived from 18 previously characterized 298
OBI strains with S mutations not present in 369 HBV genotypes B-D strains 299
infecting HBsAg+ blood donors identified three patterns of HBsAg expression 300 (Fig. 1) . These patterns were defined by the total HBsAg production estimated by 301 EIA, the IC/EC HBsAg ratio, and the intra-cellular distribution of HBsAg detected 302 by immunofluorescence (Fig. 2 & 3) . However, two genotype C controls (M92-cl2 303 and M95-cl8) presented an IC/EC ratio and IFA pattern similar to OBI pattern 2 304 but total HBsAg was similar to the pattern 1. In addition, pattern 2 TW9015-cl1 305 and pattern 3 TW6639-cl1 and TW2256-cl3 IFA appeared intermediary between 306 pattern 2 and 3. Nevertheless, there were clear differences in HBsAg expression 307
properties between HBsAg+/wild type controls and OBI strains and between 308 OBIs ( Fig. 2A-D) . 309
The differences in total HBsAg production between HBV strains, used as 310 a criterion to define the three patterns, might be due to variations in the 311 effectiveness of the HBsAg expression vector transfection into HuH-7 cells 312 despite normalization using co-transfection with a reporter plasmid and the mean 313 on July 12, 2017 by guest http://jvi.asm.org/ Downloaded from (±SD) of total IC and EC HBsAg in triplicate (Fig. 2) . In addition, using a CMV 314 promoter driven expression vector, protein overexpression may be responsible of 315 the phenotypes observed in vitro. Similarly, discrete variations in HBsAg 316 production may be masked by high protein expression levels. However, similar 317 IC and EC HBsAg levels were obtained when transfecting HuH-7 cells with an 318 entire HBV genotype C genome (not shown). Nevertheless, total HBsAg, 319 together with the intra-cellular HBsAg immunofluorescence pattern, clearly 320 differentiated patterns 1 and 2 from pattern 3 (Fig. 2B & Fig. 3 ). For the latter, 321 low total HBsAg (<50 ng) was supported by no or low IC HBsAg 322 immunofluorescence (Fig. 3) . Further studies are needed to establish whether 323 the lack of HBsAg detection in pattern 3 OBIs is related to HBsAg production 324 being terminated by an uncharacterized posttranscriptional mechanism as 325 previously suggested (9, 10), or to mutant HBsAg unrecognized by the EIA and 326 IFA assays (5, 6). The average amino acid substitution rate in the MHR and 327 over the S protein was similar in OBI sequences irrespective of HBsAg pattern 328 (MHR: 6.4% in pattern 1 vs 8.6% in pattern 2 vs 9.1% in pattern 3; S protein: 329 5.7% in pattern 1 vs 7.2% in pattern 2 vs 6.9% in pattern 3), but significantly 330 higher in OBIs than in non-OBI sequences (0.9% and 1.9% in non-OBI MHR and 331 S protein, respectively) (Fig. 1) . However, mutations D144E and G145R, 332 previously associated with reduced HBsAg detection (15), were present in three 333 pattern 3 clones (TW6639-cl1 and TW3437-cl5) or in association (HK8663-cl2) 334 and supported the immune detection escape hypothesis. The rare M75T substitution was associated with HBsAg excretion defect. 357
This mutation is located in the C-terminus part of the protein cytosolic loop that 358 contains a putative core-envelope interaction domain important for both virions 359 and HBsAg secretion (16). In previous studies, replacement of the R73, R78 and 360 R79 by uncharged residues, and the naturally occurring mutation L77R reduced 361
HBsAg secretion (16, 18). The highly restricted perinuclear IFA staining pattern 362 observed for mutant M75T in the present study (Fig. 4A) Three genotype B OBI clones -HK01556-cl2, HK6794-cl2 and TW6639-367 cl1 -with HBsAg excretion defect contained the Y100S mutation ( Fig. 1 & Fig. 2) . 368
When repaired in HK6794-cl2, excretion of HBsAg was recovered and changed 369 from pattern 2 to pattern 1. However, Y100S alone did not cause HBsAg 370 retention when introduced in M88-cl4 control (Table 3) Similarly, W74L single mutation has been described to suppress the retention 375 phenotype of L77R (16). A Y100C substitution was present in two pattern 3 OBI 376 clones (HK37 and TW3437) in agreement with previous reports associating this 377 substitution with HBsAg-negative phenotype in OBI cases (12, (19) (20) (21) . However, 378 it was also found in all pattern 2/3 clones of M92 control indicating that Y100C 379 does not play a direct role in reducing total HBsAg amounts or HBsAg reactivity 380 with commercial assays as suggested by Mello and co-authors (12). 381
Previous studies have shown that both virions and HBsAg secretion were 382 affected by mutations within three of the putative transmembrane (TM) alpha-383 helix domains TM1, TM2 and TM4 of the S protein (18, 22, 23) . Mutations in TM2 384 and TM4 may affect (i) possible intra-molecular interactions between TM 385 domains within the S protein resulting in altered protein folding and defective 386 insertion into the ER membrane, or (ii) inter-molecular interactions with peptide 387 chain of other S proteins essential for HBsAg morphogenesis (11, 23, 24) . In the 388 to result in retention and rapid degradation in the ER (25). This is in agreement 396 with the reduced total amount of HBsAg and its intra-cellular location 397 characterizing OBI pattern 2. These effects of charged residues appeared to 398 correlate with the level of free energy required to partition charged chains into a 399 lipid bilayer (25), and it may explain the similar, albeit lessened, effect of 400 substitutions with other strongly polar residues including lysine and glutamine 401 (Table 3) . However, limited changes induced by non-polar residues alanine and 402 leucine and the lack of significant change with glutamate (Table 3) Nevertheless, these data show that, like the three other transmembrane domains, 406 TM3 plays a role in the morphogenesis of HBsAg. However, the topology of the 407
HBsAg carboxy-terminal trans-membrane domains is not precisely known and 408 structural predictions rely on models that are continuously refined. 409
Defective HBsAg secretion was also reported to be associated with 410 substitutions in the MHR of OBIs (5, 13, 17, 26, 27) . Some of these substitutions 411 were observed in the OBI sequences studied here but their negative effect if any 412 on HBsAg phenotype remained unclear. For example, serine residue at position126, previously associated with a moderate decrease of HBsAg secretion (5), 414 was present in OBI pattern 1 TW5004-cl3 with no evidence of secretion defect. 415
Similarly, Q129R was found in four OBI clones irrespective of their HBsAg 416 excretion pattern (pattern 1 TW4576-cl3, pattern 2 TW0498-cl3, and pattern 3 417 TW6639-cl1 and TW8964-cl1). Moreover, the correction R129Q did not restore 418 efficient HBsAg excretion in TW0498-cl3 (Table 2 ) and neither M88-cl4 excretion 419 pattern was modified by Q129R (Table 3) . Substitution G145A was reported to 420 impair HBsAg secretion in a genotype A OBI strain, but it showed no obvious 421 effect in an Asian strain in another study (5, 13 
